MYC and neoplasm: In hepatocellular carcinoma (HCC), c-Myc represses miR-122 expression that in turn indirectly inhibits c-Myc transcription by targeting the transcription factor Dp-2 (Tfdp2) and E2F transcription factor 1 (E2f1), which are essential for tumor development [41].